menu ☰
menu ˟

A biomarker study in long-lasting amnestic mild cognitive impairment

25 Apr 2018

Mild cognitive impairment (MCI) is a heterogeneous syndrome resulting from Alzheimer’s disease (AD) as well as to non-AD and non-neurodegenerative conditions. A subset of patients with amnestic MCI (aMCI) pres...

Click here to view the full article which appeared in Alzheimer's Research & Therapy